There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Raffles Medical Group (RAFLF – Research Report) and Evolent Health (EVH – Research Report) with bullish sentiments.
Raffles Medical Group (RAFLF)
In a report released today, Llelleythan Tan from UOB Kay Hian maintained a Buy rating on Raffles Medical Group, with a price target of S$1.90. The company’s shares closed last Monday at $1.08, equals to its 52-week high of $1.08.
According to TipRanks.com, Tan is ranked #6838 out of 8414 analysts.
Currently, the analyst consensus on Raffles Medical Group is a Strong Buy with an average price target of $1.39, implying a 28.7% upside from current levels. In a report issued on June 8, RHB Capital also maintained a Buy rating on the stock with a S$1.75 price target.
See today’s best-performing stocks on TipRanks >>
Evolent Health (EVH)
In a report released yesterday, David Larsen from BTIG reiterated a Buy rating on Evolent Health, with a price target of $45.00. The company’s shares closed last Friday at $28.86.
According to TipRanks.com, Larsen is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Evolent Health is a Strong Buy with an average price target of $44.00, a 45.9% upside from current levels. In a report issued on May 31, J.P. Morgan also maintained a Buy rating on the stock.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
